Women's Health Issues
Volume 19, Issue 3 , Pages 202-210 , May 2009

Racial Differences in Women Who have a Hysterectomy for Benign Conditions

  • Gerson Weiss, MD

      Affiliations

    • New Jersey Medical School, UMDNJ, Newark, New Jersey
    • ,
  • Dorette Noorhasan, MD

      Affiliations

    • New Jersey Medical School, UMDNJ, Newark, New Jersey
    • Corresponding Author InformationCorrespondence to: Dorette Noorhasan, MD, Department of Obstetrics, Gynecology, and Women's Health, 185 South Orange Avenue, P. O. Box 1709, Newark, NJ 07101. Tel: 973-972-5266, Fax: 973-972-4574.
    • ,
  • Laura L. Schott, PhD

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Lynda Powell, PhD

      Affiliations

    • Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois
    • ,
  • John F. Randolph Jr., MD

      Affiliations

    • University of Michigan Health System, Ann Arbor, Michigan
    • ,
  • Janet M. Johnston, PhD, MPH

      Affiliations

    • Alaska Native Epidemiology Center, Anchorage, Alaska

Received 5 September 2008 ,Revised 4 March 2009 ,Accepted 5 March 2009.

References 

  1. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. Journal of the Society for Gynecologic Investigation. 2006;13:136–144
  2. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertility & Sterility. 2006;86:686–693
  3. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. Association of physical activity with development of uterine leiomyoma. American Journal of Epidemiology. 2007;165:157–163
  4. Brett KM, Marsh JV, Madans JH. Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. Journal of Womens Health. 1997;6:309–316
  5. Bump RC. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstetrics and Gynecology. 1993;81:421–425
  6. Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas. Obstetrics and Gynecology. 1999;94:395–398
  7. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. American Journal of Obstetrics and Gynecology. 2003;188:100–107
  8. England BG, Parsons GH, Possley RM, McConnell DS, Midgley AR. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clinical Chemistry. 2002;48:1584–1586
  9. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: A practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. American Journal of Epidemiology. 2001;153:1–10
  10. Folkerd EJ, Newton CJ, Davidson K, Anderson MC, James VH. Aromatase activity in uterine leiomyomata. Journal of Steroid Biochemistry. 1984;20:1195–1200
  11. Hillis SD, Marchbanks PA, Peterson HB. Uterine size and risk of complications among women undergoing abdominal hysterectomy for leiomyomas. Obstetrics and Gynecology. 1996;87:539–543
  12. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc; 1989;
  13. Howard D, Delancey JO, Tunn R, Ashton-Miller JA. Racial differences in the structure and function of the stress urinary continence mechanism. Obstetrics and Gynecology. 2000;95:713–717
  14. Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES, et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. American Journal of Obstetrics and Gynecology. 2008;198:168;e161–169
  15. Keshavarz H, Kieke B, Marchbanks P. Hysterectomy surveillance—United States 1994–1999. Morbidity and Mortality Weekly Report Surveillance Summaries. 2002;51:1–8
  16. Kjerulff KH, Guzinski GM, Langenberg PW, Stolley PD, Moye NE, Kazandjian VA. Hysterectomy and race. Obstetrics and Gynecology. 1993;82:757–764
  17. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. Journal of Reproductive Medicine. 1996;41:483–490
  18. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstetrics and Gynecology. 1997;90:967–973
  19. Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF, et al. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues. 2005;15:179–186
  20. Reddy VV, Rose LI. delta 4-3-Ketosteroid 5 alpha-oxidoreductase in human uterine leiomyoma. American Journal of Obstetrics and Gynecology. 1979;135:415–418
  21. Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstetrics and Gynecology. 2007;109:1396–1403
  22. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. British Medical Journal (Clinical Research Edition). 1986;293:359–362
  23. Sowers MF, Beebe JL, McConnell D, Randolph J, Jannausch M. Testosterone concentrations in women aged 25-50 years: Associations with lifestyle, body composition, and ovarian status. American Journal of Epidemiology. 2001;153:256–264
  24. Sowers MF, Crawford SL, Sternfeld B. SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopausal transition. Lobo, Kelsey, Marcus. Menopause: Biology and Pathobiology. San Diego: Academic Press; 2000;
  25. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstetrics and Gynecology. 2002;99:290–300
  26. Sternfeld B, Ainsworth BE, Quesenberry CP. Physical activity patterns in a diverse population of women. Preventive Medicine. 1999;28:313–323
  27. Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA. Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology. 2007;18:758–763
  28. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30:473–483
  29. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstetrics and Gynecology. 1994;83:549–555
  30. Williams VS, Jones G, Mauskopf J, Spalding J, DuChane J. Uterine fibroids: A review of health-related quality of life assessment. Journal of Womens Health (Larchmont). 2006;15:818–829
  31. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005;16:346–354
  32. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata. Fertility & Sterility. 2007;87:1108–1115
  33. Yamamoto T, Takamori K, Okada H. Estrogen biosynthesis in leiomyoma and myometrium of the uterus. Hormone and Metabolic Research. 1984;16:678–679

 The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health, DHHS, through the National Institute on Aging, the National Institute of Nursing Research and the NIH Office of Research on Women's Health (Grants NR004061; AG012505, AG012535, AG012531, AG012539, AG012546, AG012553, AG012554, AG012495). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or the NIH.

PII: S1049-3867(09)00026-7

doi: 10.1016/j.whi.2009.03.001

Women's Health Issues
Volume 19, Issue 3 , Pages 202-210 , May 2009

Article Tools

* Image Usage & Resolution